Molecular Partners AG operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Molecular Partners AG with three other
miscellaneous service companies in Europe:
sales of 10.80 million Euro [US$11.97 million]
of the United Kingdom
(£8.75 million [US$10.90 million]
Evolva Holding SA
(8.93 million Swiss Francs [US$9.01 million]
of which 100%
was Novel Food Nutritional & Pharmaceutical).
Molecular Partners AG reported sales of 10.36 million Swiss Francs (US$10.45 million)
December of 2018.
decrease of 48.3%
versus 2017, when the company's sales were 20.02 million Swiss Francs.